菜单
Telephone sharing button Contact Us linkedin sharing button LinkedIn wechat sharing button YouTube wechat sharing button Twitter mailbox sharing button info@wuxibiologics.com
arrow_left sharing button
arrow_right sharing button

Poster modified on 17/10/2023

Developability Assessment and Optimization of Antibodies and Antibody-derived Molecules at Early-Stage Discovery
Weijie Zhang, Nan Feng, Shuang Wang, Hang Zhou, Jianqing Xu, Jijie Gu and Zhuozhi Wang
WuXi Biologics, 1951 West Huifeng Road, Fengxian District, Shanghai, China

Although the safety and efficacy of a drug candidate are evaluated by sponsors and regulatory agencies, many aspects of developability of a given antibody candidate during early drug R&D are sometimes overlooked. In this poster, we outline our novel criterion of developability and general developability screening process during the early discovery stage of antibody-derived therapeutics.

 

This scientific poster was originally presented during the Festival of Biologics 2023 conference

Discuss This Poster

To discuss the data in this poster, please complete the form on the following page to connect with our experts.

Connect with our Experts